These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

609 related articles for article (PubMed ID: 22928556)

  • 1. Association of symptoms with urodynamic findings in men with overactive bladder syndrome.
    Al-Zahrani AA; Gajewski JB
    BJU Int; 2012 Dec; 110(11 Pt C):E891-5. PubMed ID: 22928556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urodynamic findings in women with refractory overactive bladder symptoms.
    Al-Zahrani AA; Gajewski J
    Int J Urol; 2016 Jan; 23(1):75-9. PubMed ID: 26417863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urgency severity scale could predict urodynamic detrusor overactivity in patients with overactive bladder syndrome.
    Chung SD; Liao CH; Chen YC; Kuo HC
    Neurourol Urodyn; 2011 Sep; 30(7):1300-4. PubMed ID: 21560153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urodynamic findings in female diabetic patients with and without overactive bladder symptoms.
    Ho CH; Tai HC; Yu HJ
    Neurourol Urodyn; 2010 Mar; 29(3):424-7. PubMed ID: 19283863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is there a difference between women with or without detrusor overactivity complaining of symptoms of overactive bladder?
    Giarenis I; Mastoroudes H; Srikrishna S; Robinson D; Cardozo L
    BJU Int; 2013 Aug; 112(4):501-7. PubMed ID: 23452071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of urinary nerve growth factor level with pathogenesis of overactive bladder.
    Yokoyama T; Kumon H; Nagai A
    Neurourol Urodyn; 2008; 27(5):417-20. PubMed ID: 17924444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding the elements of overactive bladder: questions raised by the EPIC study.
    Irwin DE; Abrams P; Milsom I; Kopp Z; Reilly K;
    BJU Int; 2008 Jun; 101(11):1381-7. PubMed ID: 18336602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between cystometric volumes, ATP release, and pH in women with overactive bladder versus controls.
    Cheng Y; Mansfield KJ; Allen W; Millard RJ; Burcher E; Moore KH
    Neurourol Urodyn; 2013 Sep; 32(7):969-73. PubMed ID: 23129360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The profiles and patterns of detrusor overactivity and their association with overactive bladder symptoms in men with benign prostatic enlargement associated with detrusor overactivity.
    Shahab N; Seki N; Takahashi R; Kajioka S; Takei M; Yamaguchi A; Naito S
    Neurourol Urodyn; 2009; 28(8):953-8. PubMed ID: 19260093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Add-on fesoterodine for residual storage symptoms suggestive of overactive bladder in men receiving α-blocker treatment for lower urinary tract symptoms.
    Kaplan SA; Roehrborn CG; Gong J; Sun F; Guan Z
    BJU Int; 2012 Jun; 109(12):1831-40. PubMed ID: 21966995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is the bladder a reliable witness for predicting detrusor overactivity?
    Hashim H; Abrams P
    J Urol; 2006 Jan; 175(1):191-4; discussion 194-5. PubMed ID: 16406907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of doxazosin with or without tolterodine in men with symptomatic bladder outlet obstruction and an overactive bladder.
    Lee JY; Kim HW; Lee SJ; Koh JS; Suh HJ; Chancellor MB
    BJU Int; 2004 Oct; 94(6):817-20. PubMed ID: 15476515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How many uncomplicated male and female overactive bladder patients reveal detrusor overactivity during urodynamic study?
    Sekido N; Hinotsu S; Kawai K; Shimazui T; Akaza H
    Int J Urol; 2006 Oct; 13(10):1276-9. PubMed ID: 17010004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urethral dilatation: Is there any benefit over cystoscopy and distension? A randomized trial in women with overactive bladder symptoms.
    Basu M; Khullar V; Duckett J
    Neurourol Urodyn; 2014 Mar; 33(3):283-8. PubMed ID: 23636866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ambulatory urodynamic monitoring of women with overactive bladder syndrome during single voiding cycle.
    Dokmeci F; Cetinkaya SE; Seval MM; Dai O
    Eur J Obstet Gynecol Reprod Biol; 2017 May; 212():126-131. PubMed ID: 28355584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes of urinary nerve growth factor and prostaglandins in male patients with overactive bladder symptom.
    Kim JC; Park EY; Hong SH; Seo SI; Park YH; Hwang TK
    Int J Urol; 2005 Oct; 12(10):875-80. PubMed ID: 16323980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathophysiological aspects of nocturia in a danish population of men and women age 60 to 80 years.
    Bing MH; Moller LA; Jennum P; Mortensen S; Lose G
    J Urol; 2007 Aug; 178(2):552-7. PubMed ID: 17570415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationships between micturition urgency and involuntary voiding dynamics in men with urinary incontinence from idiopathic detrusor overactivity.
    Cucchi A; Quaglini S; Rovereto B
    J Urol; 2007 Aug; 178(2):563-7; discussion 567. PubMed ID: 17570436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence, severity, and symptom bother of lower urinary tract symptoms among men in the EPIC study: impact of overactive bladder.
    Irwin DE; Milsom I; Kopp Z; Abrams P; Artibani W; Herschorn S
    Eur Urol; 2009 Jul; 56(1):14-20. PubMed ID: 19278775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-operative opening detrusor pressure is predictive of detrusor overactivity following TVT in patients with pre-operative mixed urinary incontinence.
    Panayi DC; Duckett J; Digesu GA; Camarata M; Basu M; Khullar V
    Neurourol Urodyn; 2009; 28(1):82-5. PubMed ID: 19089898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.